News & Views
Telix announces several key executive leadership appointments, including the establishment of an Asia-Pacific (APAC) operating region, further continuing the Company’s rapid commercial…
Read more
News,
Telix announces Richard Valeix has joined the Telix executive leadership team in the role of President, Europe, Middle East and Africa…
Read more
Telix announces it has completed a strategic manufacturing agreement with Global Medical Solutions to manufacture and supply finished unit doses of MTR products for clinical development…
Read more
Telix announces the Company’s ZIRDAC-JP study of its renal cancer imaging product demonstrates safety and tolerability in Japanese…
Read more
Telix announces the launch of the international NOBLE Registry of Telix’s ‘rest of world’ prostate cancer imaging agent and the dosing of the first…
Read more
Telix announces the Australian Therapeutic Goods Administration has accepted its prostate cancer imaging product submission and commenced the priority evaluation…
Read more
Telix Pharmaceuticals provides notice of The Annual General Meeting of Shareholders on Wednesday 12 May…
Read more
Telix announces it has completed an agreement with Grand River Aseptic Manufacturing to perform GMP manufacturing of Telix’s prostate cancer imaging…
Read more
News,
Telix is delighted to announce the appointment of Darren Patti as Chief Operating Officer, Telix Pharmaceuticals US (Inc). Darren brings with him over 15 years’ experience in radiopharmacy network management and…
Read more
Telix announces it has extended its non-exclusive global clinical and commercial supply agreements with Garching-based ITM…
Read more